Maxillary Sinus Floor Augmentation With Different Grafting Materials
Survival, Prosthesis, Peri-Implantitis, Patient Satisfaction
About this trial
This is an interventional treatment trial for Survival, Prosthesis focused on measuring Alveolar ridge augmentation, Maxillary sinus floor elevation, Patient-reported outcome measures, Dental implants, Biomaterials
Eligibility Criteria
Inclusion Criteria:
- >20 years
- Missing one or more posterior maxillary teeth
- Residual bone height of the maxillary alveolar process between 3 to 7 mm
- Width of the alveolar process ≥6.5 mm.
- Mandibular occluding teeth
Exclusion Criteria:
- Contraindications to implant therapy
- Full mouth plaque score >25%
- Progressive marginal periodontitis
- Acute infection in the area intended for implant placement
- Parafunction, bruxism, or clenching
- Psychiatric problems or unrealistic expectations
- Heavy tobacco use, define as >10 cigarettes per day
- Pregnancy
Sites / Locations
- Aalborg University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Autogenous bone graft alone
Mixture of 50% autogenous bone graft and 50% Symbios biphasic biomaterial
Mixture of 50% autogenous bone graft and 50% Symbios xenograft granules
Maxillary sinus floor augmentation with particulated autogenous bone graft alone from the zygomatic buttress area and simultaneously implant placement
Maxillary sinus floor augmentation with a mixture of 50% particulated autogenous bone graft from the zygomatic buttress area and 50% Symbios biphasic bone graft material (Biomaterial, 1.0 mm to 2.0 mm) with simultaneously implant placementand
Maxillary sinus floor augmentation with a mixture of 50% particulated autogenous bone graft from the zygomatic buttress area and 50% Symbios xenograft granules (Biomaterial, 1.0 mm to 2.0 mm) with simultaneously implant placement